Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
biotech
life sciences
national blog main
national top stories
abbvie
alkermes
allergan
boston blog main
boston top stories
buprenorphine
cannabis
cariprazine
clinical trials
drugs
eli lilly
entrepreneurship
europe
europe blog main
europe top stories
felipe jain
gail naughton
government
hair growth
hair regrowth
hair stimulation complex
histogen
innovation
investigational new drug (ind)
jess fiedorowicz
jessica jeffrey
karim calis
lumateperone
m health fairview
marc goodman
marijuana
massachusetts general hospital
medical marijuana
national institutes of health (nih)
olanzapine
What
fda
medicine
3
×
treatment
3
×
drug
alkermes
announced
antipsychotic
approval
based
benefits
called
cannabis
caveats
cbd
cells
chemical
cleared
clinical
commonly
company
compound
contains
cosmeceutical
derived
designed
diego’s
driving
effect
epidiolex
epilepsy
estimated
favor
female
gain
gets
gi
greenlight
hair
histogen
loss
Language
unset
Current search:
treatment
×
medicine
×
fda
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@techcrunch.com
5 years ago
With CBD, marijuana-based medicine gets its first greenlight from the FDA
@xconomy.com
6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing
